Breast cancer breakthrough

A drug developed to prevent osteoporosis could dramatically slow the growth of breast cancer tumours, according to research from the University of Sheffield and Kuopio University in Finland.

When tested with doxorubicin, a chemotherapy drug used to treat breast cancer, zoledronic acid was found to vitually stop progression of the disease in mice. Clinical trials on humans have now commenced. The results were published in the Journal of the National Cancer Institute.

Latest Issues

AfPP Regional Conference – Nottingham

Business School, University of Nottingham
20th September 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025

AfPP Regional Conference – Oxford

Mathematical Institute, University of Oxford
4th October 2025

BACCN Conference 2025

Blackpool
7th - 8th October 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025